FDA inspection triggers recall by Florida pharmacy

WASHINGTON — The Food and Drug Administration warned doctors and pharmacists Wednesday to avoid drugs made by a Florida specialty pharmacy called the Compounding Shop, due to potential safety problems uncovered by health inspectors.

The St. Petersburg-based pharmacy has agreed to recall all of its sterile drugs and is in the process of notifying customers, the FDA said in a statement. The agency said health care professionals should quarantine drugs from the company and not administer them to patients.

The Compounding Shop is a compounding pharmacy, which means it mixes custom formulations of drugs to meet doctors’ specifications. The FDA has cracked down on compounding pharmacies across the country, triggering several national recalls.


The inspections followed a nationwide fungal meningitis outbreak last year tied to contaminated drugs from a Massachusetts pharmacy. The outbreak sickened more than 700 Americans and killed more than 50 others.

Get Talking Points in your inbox:
An afternoon recap of the day’s most important business news, delivered weekdays.
Thank you for signing up! Sign up for more newsletters here

The FDA said a recent inspection of the Compounding Shop raised concerns about sterility problems that could lead to contamination.

Associated Press